# OnCo record anticancer-bioscience (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/anticancer-bioscience/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "anticancer-bioscience" ;
  schema:name "Anticancer Bioscience"@en ;
  schema:alternateName "Chengdu Anticancer Bioscience, Ltd."@en ;
  schema:description "Anticancer Bioscience develops tablet medicines meant to kill cancer cells that depend on the MYC gene, chosen with a test for MYC; its first drug has just entered an early trial."@en ;
  schema:url <https://onco.cc/companies/anticancer-bioscience/>, <https://www.anticancerbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.anticancerbio.com/>, <https://clinicaltrials.gov/study/NCT07864701> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/synthetic-lethality-approaches/> ;
  onco:targets <https://onco.cc/targets/myc-gene/> .